Mastocytosis: a disease of the hematopoietic stem cell.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19623287.
- Also identified by DOI 10.3238/arztebl.2008.0686 and PMC identifier PMC1867614.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
INTRODUCTION: Mastocytosis is an unusual clonal disease of the hematopoietic stem cell. METHODS: This article is based on a selective literature search and on the authors' clinical and pathological experience. RESULTS: The clinical manifestations of mastocytosis range from cutaneous mastocytosis, a common, prognostically favorable presentation, to mast cell leukemia, a rare, life-threatening disease. The mediator-induced symptoms usually respond well to H1 antihistamines. Therapeutic standards for cytoreduction in the progressive, systemic forms of mastocytosis are still lacking. DISCUSSION: Because some of the manifestations of mastocytosis are nonspecific and can be mimicked by other diseases, there is a risk of two types of diagnostic error: Mastocytosis may remain undiagnosed when it is actually present, or it may be diagnosed even though morphological and molecular findings rule out mastocytosis. Well-defined criteria should be used to differentiate mastocytosis from other diseases with a similar clinical presentation.